Type 2 innate lymphoid cells contribute to a mixed-type allergic response following topical exposure to the quaternary ammonium compound didecyldimethylammonium chloride.

Abstract

Abstract Didecyldimethylammonium chloride (DDAC) is an antimicrobial dialkyl-quaternary ammonium compound used in numerous industrial and commercial products. Clinical and animal data suggest that DDAC exposure elicits multiple types of hypersensitivity reactions. To examine the immunological mechanism behind this mixed type response and the potential involvement of ILCs, we assessed early immune responses in the skin following dermal DDAC exposure (0.25% and 0.5%) in a BALB/c murine model. DDAC exposure resulted in a rapid and dramatic increase in the Th2-skewing and ILC2 activating cytokine TSLP in the skin. Correspondingly, dermal ILC2s were activated 24 hours after DDAC exposure, resulting in increased levels of CD25, ICOS and KLRG1, and decreased CD127 on a per cell basis throughout a 7 day period of exposure. Following ILC2 activation, the Th2 cytokine IL-4 was found to be elevated compared to control mice in total ear protein lysate in the 0.5% DDAC treated mice. To determine a functional role for ILC2s in DDAC induced sensitization we used Rag2−/− mice, which lack mature T and B cells. ILC2s from Rag2−/− were similarly activated by DDAC and importantly, produced significant levels of IL-4 (0.5%DDAC) and IL-5 (0.25% and 0.5%) in the skin. These data indicate that ILC2s contribute to Th2 immune responses early after DDAC exposure. ILC2s have been previously implicated allergic responses, but to our knowledge have not been thoroughly investigated in chemical sensitization. These results indicate that skin resident ILC2s become activated and produce TH2 cytokines following exposure to DDAC, providing a possible mechanism for the development of a mixed-type allergic response commonly observed with chemical sensitizers.